Duke Jennifer D, Reisenauer Janani
Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
Division of Thoracic Surgery, Mayo Clinic Rochester, Rochester, MN, USA.
Expert Rev Respir Med. 2023 Mar;17(3):213-221. doi: 10.1080/17476348.2023.2192929. Epub 2023 Mar 22.
Lung cancer remains the deadliest form of cancer in the world. Screening through low-dose CT scans has shown improved detection of pulmonary nodules; however, with the introduction of robotic bronchoscopy, accessing and biopsying peripheral pulmonary nodules from the airway has expanded. Improved diagnostic yield through enhanced navigation has made robotic bronchoscopy an ideal diagnostic technology for many proceduralists. Studies have demonstrated that robotic bronchoscopes can reach further with improved maneuverability into the distal airways compared to conventional bronchoscopes.
This review paper highlights the literature on the technological advancements associated with robotic bronchoscopy and the future directions the field of interventional pulmonary may utilize this modality for in the treatment of lung cancer. Referenced articles were included at the discretion of the authors after a database search of the particular technology discussed.
As the localization of target lesions continues to improve, robotic platforms that provide reach, stability, and accuracy paves the way for future research in endoluminal treatment for lung cancer. Future studies with intratumoral injection of chemotherapy and immunotherapy and ablation modalities are likely to come in the coming years.
肺癌仍然是全球最致命的癌症形式。低剂量CT扫描筛查已显示出对肺结节的检测有所改善；然而，随着机器人支气管镜检查的引入，从气道进入外周肺结节并进行活检的范围得到了扩大。通过增强导航提高诊断率使机器人支气管镜检查成为许多手术医生理想的诊断技术。研究表明，与传统支气管镜相比，机器人支气管镜能够以更好的机动性深入到更远端的气道。
本文综述重点介绍了与机器人支气管镜检查相关的技术进展以及介入肺科领域未来可能利用这种方式治疗肺癌的方向。在对所讨论的特定技术进行数据库搜索后，作者酌情纳入了参考文献。
随着靶病变定位的不断改善，提供深入性、稳定性和准确性的机器人平台为肺癌腔内治疗的未来研究铺平了道路。未来几年可能会开展肿瘤内注射化疗、免疫治疗和消融方式的研究。
